Effect of ayurvedic drug Divya Trighan in patients with increased uric acid.

Efficacy of traditional Ayurvedic formulation (Divya Trighan) in patients with Hyperuricemia: a single-arm, open-label, prospective, observational study.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055433

Enrollment

Registered

2023-07-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. The subject with raised uric acid level in blood or urine (male: = 8.5 mg/dl and female = 7.3mg/dl) 2. Males or Females of age limit 18 to 60 years. 3. Patient agrees to provide informed consent. 4. Patient willing to participate in the study and ready to comply with study protocols. 5. No alcohol or drug dependency.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation, intent to become pregnant. 2. The subject with complications of pre-existing comorbidities or surgical intervention or undergone dialysis in last 3 month. 3. The subject with known history of uncontrolled DM and HTN. 4. The subject not willing to provide consent. 5. The subject not willing to comply with the protocol

Design outcomes

Primary

Measure	Time frame
To assess the change in Uric acid levels after treatment with Divya Trighan in patients with Hyperuricemia.Timepoint: Baseline, 4 weeks, 8 weeks	—

Secondary

Measure	Time frame
•Change in the Quality of life of patients with SF-36 questionnaireTimepoint: day 1,day 30,day 60	—

Countries

India

Contacts

Public ContactDr Anurag Sharma

Patanjali Yog Gram

clinical.investigator@prft.in7302254792

Outcome results